John Evans
About John Evans
John Evans is the CEO and a board member of Beam, known for his significant contributions to the biotechnology and pharmaceutical sectors.
John Evans - Title
John Evans is the Chief Executive Officer and a Board Member at Beam. He joined the company in 2017, bringing with him a wealth of experience from various high-level positions in the pharmaceutical industry.
John Evans - Background
Prior to his role at Beam, John Evans was a key early employee and part of the leadership team at Agios Pharmaceuticals. At Agios, he served in multiple senior roles including Senior Vice President for Corporate Development and Portfolio Leadership, and IDH Portfolio Executive. Additionally, Evans has work experience with organizations such as Infinity Pharmaceuticals, McKinsey & Company in their Pharmaceuticals practice, and MedImmune.
John Evans - Achievements at Agios Pharmaceuticals
While at Agios Pharmaceuticals, John Evans was instrumental in significant developments. He played a crucial role in initiating and leading the company's landmark alliance with Celgene. Evans also co-led Agios's strategic expansion into rare genetic diseases, showcasing his strategic vision and leadership.
John Evans - Education
John Evans has a strong educational foundation that complements his extensive professional experience. He holds an M.B.A. in Healthcare Management from Wharton and a Masters in Biotechnology from the University of Pennsylvania. Additionally, he earned a B.A. in English with distinction from Yale University.